Australian Equities
After reporting season wrapped up for Australian banks it is worth noting that two thirds of the 5% rise in the big four’s $45bn pre-tax profit in 2014 was due to reduction in provisions for bad and doubtful debts. These are now at a 20 year low. With the macroeconomic picture deteriorating for Australia it seems likely that the growth in the property market, and in mortgages, should slow going forward. We take a cautious view on Australian banks given this, and the increasingly stringent regulatory and capital environment.
Wesfarmers provided a trading update in which Coles had the strongest sales growth in 18 months, with same-store sales up 4.3% in three months. It has now had 26 consecutive quarters of same-store growth. Bunnings and Officeworks saw sales rise around 8%, with Target and Kmart the weak-spots. Wesfarmers is cashed-up after the sale of its insurance business and the market awaits how it will deploy capital.
Incitec Pivot reported an underlying FY net profit of $355m, up 21%, and ahead of market expectations. This was driven by upside in the US ammonia business, currency moves, and the deleveraging of the balance sheet. Overall fertiliser was stronger, and explosives weaker than expected.
Medibank Private was sold to institutions at $2.15 a share, whilst the retail component was capped at $2.0, netting the government $5.7bn. This puts it at 23X forecast earnings, a 15% premium to NIB, and definitely priced for delivery of its putative cost-saving measures. The multiple put it on a similar pricing to Japara, but behind stocks like Ramsay and Healthscope.
News Limited reported underlying profit of US$170m in its first quarter, up from $141m the prior year. It noted “tangible improvement” in the Australian business. It beat consensus revenues of $2.07bn with a $2.15bn headline.
Resmed announced tie-ups with Apple and Nintendo as it tries to broaden its sales base in to consumer health products outside their natural clinical market. Beyond the revenues directly generated by such licensing, presumably the hope is that this will lead to greater diagnosis of sleep apnoea and encourage take-up of its high margin product.
International Equities
With growth topping that of other developed nations, and a firm dollar, the U.S. marked a record $164.3bn inflow of foreign portfolio investments in September. The previous record was an inflow of $139.7bn in March 2010. Whilst we will keep an eye on such numbers we continue to believe that the U.S. remains the most compelling investment case in international markets at present.
Another metric we are keeping an eye on is the boom in global mergers and acquisitions. These have burst through the $US3 trillion threshold for the first time since before the financial crisis, fuelled by ultra-low borrowing costs and high stock prices. The high stock prices have encouraged acquirers to make scrip bids for targets. Cash-only deals represent 55% of announced transactions this year, the lowest proportion since 2003. Booms in M&A may portend a subsequent pullback as insiders view their stock as overvalued, and executives aggressively pursue growth. A bust has followed many of the previous M&A booms, though of course the timing is impossible to call. We will continue to watch this closely.
One of the recent major deals announced was an agreed $35bn takeover of Baker Hughes by Halliburton. The bid was a cash and stock purchase, and was the biggest oil-services deal on record. The combined company would still be smaller than Schlumberger, the leader in the field. If the oil price remains low further consolidation in the energy sector can be expected.
Rates / FX / Commodities
As expected the U.S. Federal Reserve formally ended its bond-buying program in October and signalled no change in its low-interest-rate policy. Though for the Fed-watchers out there it did drop characterisation of U.S. labour market slack as “significant”. I would expect the Fed language to continue to slowly change over the coming months.
In an unexpected move the Chinese central bank took 0.4% off the one-year loan rate to 5.6%, while knocking just a quarter of a percentage point off the one-year saving rate to 2.75%. It is unclear how effective the rate cut will be as private businesses, which are the true force behind Chinese growth, cannot access these rates.
Japan’s lapse into recession has brought a tide of investment to Australia, with Japanese investors buying $21.7bn in Australian assets over the 12 months ended in September. That’s the fastest rate of buying in nearly four years and is one factor that had been sustaining the Australian dollar’s value. By contrast, a year earlier in the 12 months to September 30, 2013, Japanese investors were net sellers of Australian assets, offloading $33bn. Japanese buying of Australian bonds represents about 6% of international flows, whereas Australia represents 1%-2% of the global bond market.
Oil prices dropped dramatically after OPEC announced it would not cut production, and would not meet again until the middle of 2015. Saudi Arabia resisted calls to cut from members such as Iran and Venezuela that need prices above $100 a barrell to balance their budgets. As we have witnessed in iron ore, what is rational for the market may not be rational for individual actors. In the case of Saudi Arabia, who are the only swing producer of consequence in OPEC, it has previously cut production only to lose market share and provide profits to other states. It seems likely that Saudi Arabia wishes to keep the oil prices low for a period to flush out high-cost producers, including some shale producers in the U.S., and consolidate its market share. This is not likely to be a short-term dip.
BHP CEO Andrew Mackenzie said the time for massive expansions in iron-ore production has ended. Which perhaps is an obvious statement.
Portfolios
In the Australian portfolio we sold Fletcher Building (FBU) as the NZ building cycle looks to be tipping over, and the uptick in Australian activity impacts too small a portion of FBU’s EBIT to justify holding the position. We also topped up Sonic Healthcare (SHL) to take advantage of recent weakness. This came after the company lowered guidance to 2%-4% growth, from 5%, with the street expecting somewhere around 7%. SHL is still well placed to benefit from AUD weakness, and potentially the post-budget pullback in health spending has played out already. We sold down half our Origin position after the OPEC announcement. We added a position in Pact Group as a good quality defensive. It trades at an approximately 20% FY15 discount to Orora and Amcor, and North American comparables, and provides a div yield of nearly 5%.
In the international value portfolio we reduced American Express (AXP) with the proceeds to cash. Electronic transactions are still a growth area but AXP is coming under pressure from new entrants to the field. For example Costco U.S., with $30bn of in-store spending, is said to be exploring a new partnership for its U.S. cards. Costco spending represents around 4% of AXP’s domestic spending. We are taking a slightly more cautious approach by reducing our holding.
In the International growth portfolio we sold United Rentals and bought Fedex. United Rentals has performed well this year though with U.S. construction slowing down, and with falling fuel prices providing a significant tailwind for Fedex, we saw the greater opportunity for returns with Fedex. We also increased our position is Sumitomo Mitsui Financial Group as we see the potential for Japan to outperform. We sold ITV as guidance failed to meet market expectations. We sold Bank of America after a solid rally since the middle of the year. We bought Intel as their technology lead is finally delivering returns, and dominance in the growing server / cloud market and increasing in-roads in mobile provide a positive backdrop. We bought Las Vegas Sands on the view that Macau weakness is more than priced in and Japan could be a big boost if gaming is opened up there.
Please be in contact if you wish to discuss any of these themes further, or wish to make any changes to your portfolios.